Skip to main content
QbD in Pharmaceutical Development

QbD in Pharmaceutical Development

Building Quality into Every Stage
of Development

Quality cannot be tested into a pharmaceutical product it must be designed into it from the very beginning.

Quality by Design (QbD) is a systematic, science-based, and risk-driven approach that ensures quality is built into the product and manufacturing process from the earliest stages of development.

Understanding
the Product & Process

By understanding the relationship between formulation variables, material attributes, and process parameters, QbD enables the development of robust products that consistently meet predefined quality targets.

Why Is QbD Critical in
Pharmaceutical Development?

  •  Enhanced Product Understanding

    A comprehensive understanding of Critical Quality Attributes (CQAs), Critical Material Attributes (CMAs), and Critical Process Parameters (CPPs) enables informed development decisions.


  •  Improved Process Robustness

    Optimized formulation and manufacturing processes minimize variability and ensure consistent product performance across commercial batches.


  • Risk-Based Development

    Scientific risk assessment identifies potential challenges early, reducing development failures and accelerating decision-making.


  • Regulatory Confidence

    QbD aligns with ICH Q8(R2), Q9, and Q10 principles and supports regulatory submissions by demonstrating a thorough understanding of product and process design.


  •  Efficient Scale-Up and Technology Transfer

    A well-established design space facilitates smoother scale-up and successful transfer from laboratory to commercial manufacturing.


  • Lifecycle Management

    Continuous process understanding supports product improvements while maintaining consistent quality throughout the product lifecycle.



QbD at a Glance

Quality Target Product Profile (QTPP)

Identify Critical Quality Attributes (CQAs)

Risk Assessment

Formulation & Process Optimization (DoE)

Establish Design Space

Control Strategy

Consistent Commercial Manufacturing


The Key Takeaway

Organizations that integrate QbD into pharmaceutical development are better positioned to deliver high-quality medicines, achieve regulatory confidence, and accelerate commercialization while ensuring consistent patient outcomes.

Quality by Design is not simply a regulatory requirement—it is a scientific mindset that enables:

  • Accelerated Development
  • Manufacturing Reliability
  • Long-Term Product Success
  • Robust Processes

Ultimately delivering safer, more consistent
medicines to patients.